Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the Adipose Derived Stromal Cells-Stromal Vascular Fraction in Idiopathic Pulmonary Fibrosis

P. Ntolios (Alexandroupolis, Greece), E. Manoloudi (Alexandroupolis, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), P. Steiropoulos (Alexandroupolis, Greece), S. Anevlavis (Alexandroupolis, Greece), D. Bouros (Athens, Greece), M. Froudarakis (Alexandroupolis, Greece)

Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Session: Clinical news in idiopathic interstitial pneumonias
Session type: Oral Presentation
Number: 545
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Ntolios (Alexandroupolis, Greece), E. Manoloudi (Alexandroupolis, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), P. Steiropoulos (Alexandroupolis, Greece), S. Anevlavis (Alexandroupolis, Greece), D. Bouros (Athens, Greece), M. Froudarakis (Alexandroupolis, Greece). Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the Adipose Derived Stromal Cells-Stromal Vascular Fraction in Idiopathic Pulmonary Fibrosis. 545

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: